Spotlight On... VA signs R&D agreement for medical device cybersecurity; Mainstay Medical raised $33.8 million in financing; Biotronik launched the U.S.'s smallest MR conditional pacing lead; and more...

The U.S. Department of Veteran Affairs (VA) has signed a signed Cooperative Research and Development Agreement Program (CRADA) for medical devices cybersecurity standards and certification approaches with Underwriters Laboratories (UL), a scientific safety organization. The pair will work to improve standards and practices for network connectable medical devices, medical device data systems and related health IT. "Working together with the VA, we will contribute to industry-wide situational awareness of both medical device vulnerabilities and threats," said Anura Fernando, UL Principal Engineer for Medical Software & Systems Interoperability, in a statement. "We believe that this project will positively impact the direction that manufacturers take in improving the overall security posture of medical cyber assets." More

> Mainstay Medical, which is developing a neurostimulation implant, raised €30 million ($33.8 million) to support commercialization in Europe and a clinical trial in the U.S. Release

> Biotronik launched its Solia S ProMRI with a 5.6 French lead body, the smallest MR conditional pacing lead available in the U.S. Release

> The American Gastroenterological Association released a position statement on the management of gastroesophageal reflux disease (GERD) using minimally invasive surgery. Release

Suggested Articles

Grail published new data showing that its cancer-screening blood test is now able to spot more than 50 types of the disease and across all stages.

Battelle received an emergency go-ahead from the FDA over the weekend to deploy its decontamination system for N95 respirator masks.

The limited supply of ventilators is one of the chief concerns facing hospitals as they prepare for more COVID-19 cases.